PhD Terhi Jokilehto - UTU Research Portal

Terhi Jokilehto
PhD

- Coordinator,
- Project Coordinator
Research Services (Research Affairs)

tejojo@utu.fi

+358 29 450 2897

+358 50 475 4197

Office: floor 6A

Publications

Glucocorticoid receptor-induced non-muscle caldesmon regulates metastasis in castration-resistant prostate cancer (2023)
- Oncogenesis
Virtanen Verneri, Paunu Kreetta, Kukkula Antti, Niva Saana, Junila Ylva, Toriseva Mervi, Jokilehto Terhi, Mäkelä Sari, Huhtaniemi Riikka, Poutanen Matti, Paatero Ilkka, Sundvall Maria
(A1 Refereed original research article in a scientific journal)
Protein phosphatase 2A (PP2A) inhibitor CIP2A indicates resistance to radiotherapy in rectal cancer (2018)
- Cancer Medicine
Eva-Maria Birkman, Adam Elzagheid, Terhi Jokilehto, Tuulia Avoranta, Eija Korkeila, Jarmo Kulmala, Kari Syrjänen, Jukka Westermarck, Jari Sundström
(A1 Refereed original research article in a scientific journal)
EGFR gene copy number predicts response to anti-EGFR treatment in RAS wild type and RAS/BRAF/PIK3CA wild type metastatic colorectal cancer (2017)
- International Journal of Cancer
ålgars Annika, Sundström Jari, Lintunen M, Jokilehto T, Kytölä S, Kaare M, Vainionpää R, Orpana A, österlund P, Ristimäki A, Carpen O, Ristamäki Raija
(A1 Refereed original research article in a scientific journal)
Heterogeneous EGFR Gene Copy Number Increase Is Common in Colorectal Cancer and Defines Response to Anti-EGFR Therapy (2014)
- PLoS ONE
Algars A, Avoranta T, Osterlund P, Lintunen M, Sundstrom J, Jokilehto T, Ristimaki A, Ristamaki R, Carpen O
(A1 Refereed original research article in a scientific journal)
Prolyl hydroxylase PHD3 enhances the hypoxic survival and G1 to S transition of carcinoma cells (2011)
- PLoS ONE
Högel H, Rantanen K, Jokilehto T, Grenman R, Jaakkola P
(A1 Refereed original research article in a scientific journal)
Hypoxic Conversion of SMAD7 Function from an Inhibitor into a Promoter of Cell Invasion (2010)
- Cancer Research
Heikkinen PT, Nummela M, Jokilehto T, Grenman R, Kähäri VM, Jaakkola PM
(A1 Refereed original research article in a scientific journal)
Retention of prolyl hydroxylase PHD2 in the cytoplasm prevents PHD2-induced anchorage-independent carcinoma cell growth (2010)
- Experimental Cell Research
Jokilehto T, Högel H, Heikkinen P, Rantanen K, Elenius K, Sundström J, Jaakkola P
(A1 Refereed original research article in a scientific journal)
The role of HIF prolyl hydroxylases in tumour growth (2010)
- Journal of Cellular and Molecular Medicine
Jokilehto T, Jaakkola PM
(A1 Refereed original research article in a scientific journal)
p38 alpha and p38 delta mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells (2007)
- Oncogene
Junttila MR, Ala-Aho R, Jokilehto T, Peltonen J, Kallajoki M, Grenman R, Jaakkola P, Westermarck J, Kahari VM
(A1 Refereed original research article in a scientific journal)
Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness (2006)
- Clinical Cancer Research
Jokilehto T, Rantanen K, Luukkaa M, Heikkinen P, Grenman R, Minn H, Kronqvist P, Jaakkola PM
(A1 Refereed original research article in a scientific journal)
Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases (2004)
- Biochemical Journal
Marxsen JH, Stengel P, Doege K, Heikkinen P, Jokilehto T, Wagner T, Jelkmann W, Jaakkola P, Metzen E
(A1 Refereed original research article in a scientific journal)